Kintayl Capital LP purchased a new position in shares of ChampionX Corporation (NASDAQ:CHX - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 356,742 shares of the company's stock, valued at approximately $10,631,000. ChampionX comprises about 7.6% of Kintayl Capital LP's holdings, making the stock its 2nd biggest holding. Kintayl Capital LP owned 0.19% of ChampionX at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. raised its position in ChampionX by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 19,964,329 shares of the company's stock worth $542,830,000 after buying an additional 227,627 shares during the last quarter. Westchester Capital Management LLC increased its holdings in shares of ChampionX by 14.7% during the 4th quarter. Westchester Capital Management LLC now owns 3,243,134 shares of the company's stock valued at $88,181,000 after purchasing an additional 414,995 shares in the last quarter. Northern Trust Corp increased its holdings in shares of ChampionX by 10.9% during the 4th quarter. Northern Trust Corp now owns 2,917,978 shares of the company's stock valued at $79,340,000 after purchasing an additional 286,853 shares in the last quarter. AQR Arbitrage LLC increased its holdings in shares of ChampionX by 7.4% during the 4th quarter. AQR Arbitrage LLC now owns 2,808,543 shares of the company's stock valued at $75,859,000 after purchasing an additional 194,219 shares in the last quarter. Finally, Norges Bank purchased a new position in shares of ChampionX during the 4th quarter valued at approximately $74,032,000. 98.99% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, Stifel Nicolaus lifted their target price on shares of ChampionX from $39.00 to $40.00 and gave the company a "buy" rating in a report on Monday, May 5th.
Check Out Our Latest Stock Report on CHX
ChampionX Price Performance
Shares of NASDAQ:CHX remained flat at $25.81 during trading on Friday. 1,273 shares of the stock traded hands, compared to its average volume of 2,860,781. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.62 and a current ratio of 2.25. The stock has a market capitalization of $4.94 billion, a P/E ratio of 17.09, a price-to-earnings-growth ratio of 5.04 and a beta of 1.49. The business's 50-day simple moving average is $25.58 and its two-hundred day simple moving average is $27.04. ChampionX Corporation has a 52-week low of $21.92 and a 52-week high of $35.68.
ChampionX (NASDAQ:CHX - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.41 by $0.09. ChampionX had a net margin of 8.20% and a return on equity of 19.25%. The firm had revenue of $864.46 million for the quarter, compared to analysts' expectations of $900.59 million. During the same quarter last year, the company earned $0.50 EPS. The firm's revenue for the quarter was down 6.3% compared to the same quarter last year. On average, equities research analysts predict that ChampionX Corporation will post 1.92 EPS for the current fiscal year.
ChampionX Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Thursday, July 3rd will be paid a $0.095 dividend. The ex-dividend date is Thursday, July 3rd. This represents a $0.38 dividend on an annualized basis and a yield of 1.47%. ChampionX's dividend payout ratio is currently 25.17%.
About ChampionX
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Further Reading
Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
